Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children
Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue; Rhabdomyosarcoma, Pelvic; Rhabdomyosarcoma, Abdominal Interventions: Procedure: Abdominal Surgery; Drug: Doxorubicin; Radiation: Intra-Operative Radiation Sponsor: M.D. Anderson Cancer Center Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer & Oncology | Chemotherapy | Children | Research | Rhabdomyosarcoma | Sarcomas | Study | Undifferentiated Carcinoma